Growth-hormone/insulin-like growth factor (GH/IGF-I) axes - research

Categories:
Countering neurodegeneration
Genes of GH/IGF-I axes and influence on aging
IGF-1 levels
See also: Endocrine system and hormones - research
 
 
Stem cells: Blood, Bone marrow. IGF-1 levels, IL-6 levels, Bone marrow fat levels
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age; with an increase in quality of surviving stem cells: correlation with cytokines
S.K. Brusnahan et al. 2010. article
 
Insulin growth factor(IGF) pathway: Cancer cell metastasis, Cancer: Cancer cell metastasis and the IGF pathway 
Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective
M. Kamrava et al. 2010. review
 
Longevity factors and mechanisms: Genetics, Insulin/IGF-1 pathway
Genetic Variation in Insulin/IGF-1 Signaling Pathways and Longevity
E. Ziv, D. Hu. 2010. review
 
Neurodegeneration, Seven types of damage: Protein aggregates, Insulin/IGF Signaling Pathway
Countering Neurodegeneration by Reducing the Activity of the Insulin/IGF Signaling Pathway: Current Knowledge and Future Prospects
E. Cohen. 2010. review
 
Endocrine system and hormones
Growth hormone, insulin and aging: The benefits of endocrine defects
A Bartke. 2010. review
 
Vasoprotective effects: GH replacement, Insulin-like growth factor 1 (IGF-1)
Vasoprotective Effects of Life Span-Extending Peripubertal GH Replacement in Lewis Dwarf Rats
Z. Ungvari et al. 2010. article
 
Hormones: Hypothalamo-pituitary axis, Growth-hormone/insulin-like growth factor (GH/IGF-I) axes
Aging and hormones of the hypothalamo-pituitary axis: Gonadotropic axis in men and somatotropic axes in men and women
J.D. Veldhuis. 2008. review
 
 
back to Specific pathways and proteins - research
 
Comments